Azilect Tablet
Product Images NDC 68546-229

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azilect (NDC 68546-229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Neuroscience, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of rasagiline mesylate, the active ingredient in Azilect tablets by Teva Neuroscience, Inc. The diagram shows the molecular arrangement including the mesylate group (CH3SO3H) attached to the rasagiline molecule.*

FDA Label Image

Logo (Image 2)

FDA Label Image

Image (Image 3)

Azilect 0.5 mg tablets packaging label with proprietary and generic name (rasagiline tablets), strength, and quantity (30 tablets). Distributed by Teva Pharmaceuticals USA, Inc., with dosage form oral tablet. The label includes serialization coding area, storage instructions, and barcode.*

FDA Label Image

Image (Image 4)

Azilect 1 mg oral tablets label showing the active ingredient rasagiline mesylate. The label indicates a package size of 30 tablets, manufactured by Teva Neuroscience, Inc. It includes storage instructions and regulatory information along with a barcode and NDC 68546-229-56.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.